Study S000699

Dulaglutide and Calorie Restrict Diet (CRD) in Overweight/Obese Patients With Polycystic Ovary Syndrome

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT04876027
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 68
Start: 2021-05-15
Primary completion: 2022-04-30
Lead sponsor: Shanghai 10th People's Hospital
Conditions: Polycystic Ovary Syndrome
Interventions: DRUG:GLP-1 RAs; OTHER:calorie restricted diet
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

the change in visceral adipose tissue [until achievement of the weight loss target,an average of 12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.